Chemomab Therapeutics (CMMB) Amortization - Deferred Charges (2018 - 2019)
Chemomab Therapeutics posted quarterly Amortization - Deferred Charges of $12.6 million for Q3 2019, up 17377.78% year-on-year from N/an in Q3 2018, and up 69811.11% on a QoQ basis from $18000.0 in Q2 2019.
Chemomab Therapeutics (CMMB) has 2 years of Amortization - Deferred Charges data on file, last reported at $12.6 million in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization - Deferred Charges (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 12.58 Mn |
| Sep 30, 2019 | 12.58 Mn |
| Jun 30, 2019 | 18,000.00 |
| Jun 30, 2019 | 18,000.00 |
| Sep 30, 2018 | 72,000.00 |
| Sep 30, 2018 | 72,000.00 |
| Jun 30, 2018 | 806,000.00 |
| Jun 30, 2018 | 806,000.00 |